Myriad Genetics, Inc. (MYGN)
- Insider Monkey
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript May 7, 2024 Myriad Genetics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by, and welcome to Myriad Genetics First Quarter 2024 Earnings Conference Call. At […]
- Zacks
Myriad Genetics (MYGN) Posts Narrower-Than-Estimate Loss in Q1
Myriad Genetics (MYGN) first-quarter average revenue per test across its product portfolio benefited from expanded coverage and ongoing efforts in revenue cycle management.
- Zacks
Myriad (MYGN) Reports Q1 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Myriad (MYGN) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
